Title

Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events

UMMS Affiliation

Center for Outcomes Research; Department of Medicine, Division of Cardiovascular Medicine

Publication Date

2007-12-27

Document Type

Article

Subjects

Angioplasty, Balloon, Coronary; Cohort Studies; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Regression Analysis; Thrombolytic Therapy; Time Factors; Treatment Outcome

Disciplines

Circulatory and Respiratory Physiology | Health Services Research | Pathological Conditions, Signs and Symptoms | Therapeutics

Abstract

OBJECTIVE: Treatment delays may result in different clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who receive fibrinolytic therapy vs primary percutaneous coronary intervention (PCI). The aim of this analysis was to examine how treatment delays relate to 6-month mortality in reperfusion-treated patients enrolled in the Global Registry of Acute Coronary Events (GRACE).

DESIGN: Prospective, observational cohort study.

SETTING: 106 hospitals in 14 countries.

PATIENTS: 3959 patients who presented with STEMI within 6 h of symptom onset and received reperfusion with either a fibrin-specific fibrinolytic drug or primary PCI.

MAIN OUTCOME MEASURES: 6-month mortality.

METHODS: Multivariable logistic regression was used to assess the relationship between outcomes and treatment delay separately in each cohort, with time modelled with a quadratic term after adjusting for covariates from the GRACE risk score.

RESULTS: A total of 1786 (45.1%) patients received fibrinolytic therapy, and 2173 (54.9%) underwent primary PCI. After multivariable adjustment, longer treatment delays were associated with a higher 6-month mortality in both fibrinolytic therapy and primary PCI patients (p

CONCLUSIONS: Treatment delays in reperfusion therapy are associated with higher 6-month mortality, but this relationship may be even more critical in patients receiving fibrinolytic therapy.

DOI of Published Version

10.1136/hrt.2006.112847

Source

Heart. 2007 Dec;93(12):1552-5. Epub 2007 Jun 25. Link to article on publisher's site

Journal/Book/Conference Title

Heart (British Cardiac Society)

Related Resources

Link to Article in PubMed

PubMed ID

17591643

Link to Full Text

Share

COinS